Synthesis and pharmacological screening of novel meso-substituted porphyrin analogs

42Citations
Citations of this article
40Readers
Mendeley users who have this article in their library.
Get full text

Abstract

A novel series of mesotetrakis[aryl]-21H,23H-porphyrin derivatives 2a-j was synthesized from the condensation of aldehyde derivatives 1a-j with pyrrole in the presence of p-toluenesulfonic acid. The synthesized porphyrins were considered as a model to study the free radical-induced damage of biological membranes and the protective effects of these porphyrins. It was found that these compounds effectively inhibit the free radical-induced oxidative hemolysis of red blood cells. Compounds 2c and 2d which bear a sulfur atom, a nitro group, and a chlorine atom exhibited markedly higher antihemolysis activity than the other analogous. Compounds 2a, 2c, 2d, and 2j showed the highest protection activity against DNA damage induced by the bleomycin-iron complex. Compounds 2d, 2f, 2i, and 2j were proved to exhibit antioxidative activity. A newly synthesized series of mesotetrakis[aryl]-21H,23H-porphyrin derivatives 2a-j was considered as a model to study the free radical-induced damage of biological membranes and the protective effects of these porphyrins. Compounds 2c and 2d bearing a sulfur atom, a nitro group, and a chlorine atom exhibited markedly higher antihemolysis activity than the other analogs. Compounds 2a, 2c, 2d, and 2j showed the highest protection activity against DNA damage. Copyright © 2013 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Cite

CITATION STYLE

APA

Fadda, A. A., El-Mekawy, R. E., El-Shafei, A. I., & Freeman, H. (2013). Synthesis and pharmacological screening of novel meso-substituted porphyrin analogs. Archiv Der Pharmazie, 346(1), 53–61. https://doi.org/10.1002/ardp.201200313

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free